Hamlet Pharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.
CEO
Chairman Of The Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Catharina Svanborg | 50,19 | 50,19 | 2021-03-31 |
| Nordnet Pensionsförsäkring | 5,35 | 5,51 | 2021-03-31 |
| Hans Nygren | 1,87 | 1,87 | 2021-03-31 |
| FV Group AB | 1,78 | 1,78 | 2021-03-31 |
| Avanza Pension | 1,60 | 0,32 | 2021-03-31 |
| Fredrik Herslow | 0,84 | 0,86 | 2021-03-31 |
| Swedbank Försäkring | 0,56 | 0,56 | 2021-03-31 |
| Livförsäkringsbolaget Skandia | 0,29 | 0,06 | 2021-03-31 |
| Handelsbanken Liv Försäkring AB | 0,24 | 0,24 | 2021-03-31 |
| Bo Göhl | 0,22 | 0,22 | 2021-03-31 |
2021-05-21 Delårsrapport 2021-Q3
2021-08-27 Bokslutskommuniké 2021
2021-11-11 Delårsrapport 2022-Q1
2021-11-25 Årsstämma 2021